Fund Holdings — SUPERSTRING CAPITAL MANAGEMENT LP

Total Portfolio Value:
$113.87M
Total Bought:
$47.74M
Total Sold:
$38.92M
Net Transaction:
+$8.82M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
ORIC Pharmaceuticals, Inc.(ORIC)949,5221,580,745+631,223$9.73M$12.76M11.20%+$3.02M
Terns Pharmaceuticals Inc1,348,5462,020,562+672,016$11.25M$11.19M9.83%-$53.0K
Zai Lab LimitedADR(ZLAB)626,932403,630-223,302$15.13M$10.57M9.28%-$4.56M
NovoCure Limited(NVCR)392,711286,970-105,741$6.14M$8.55M7.51%+$2.41M
BridgeBio Pharma, Inc.(BBIO)226,684262,141+35,457$5.77M$7.19M6.32%+$1.42M
Cogent Biosciences, Inc.(COGT)0910,865+910,865$0$7.10M6.24%+$7.10M
Cytokinetics, Incorporated(CYTK)215,798129,389-86,409$11.39M$6.09M5.35%-$5.31M
Structure Therapeutics IncADS227,047216,811-10,236$9.97M$5.88M5.16%-$4.09M
IDEAYA Biosciences, Inc.(IDYA)0227,102+227,102$0$5.84M5.13%+$5.84M
UroGen Pharma Ltd.(URGN)0301,206+301,206$0$3.21M2.82%+$3.21M
Summit Therapeutics Inc.(SMMT)0164,564+164,564$0$2.94M2.58%+$2.94M
Instil Bio, Inc.(TIL)107,545148,017+40,472$7.24M$2.83M2.48%-$4.41M
Protagonist Therapeutics Inc068,892+68,892$0$2.66M2.34%+$2.66M
Insmed Incorporated(INSM)035,966+35,966$0$2.48M2.18%+$2.48M
Fate Therapeutics, Inc.(FATE)1,466,9341,379,556-87,378$5.13M$2.28M2.00%-$2.86M
Legend Biotech CorporationADS(LEGN)60,51569,594+9,079$2.95M$2.26M1.99%-$684.3K
Protara Therapeutics, Inc.(TARA)0360,000+360,000$0$1.90M1.67%+$1.90M
Cabaletta Bio, Inc.(CABA)131,795822,293+690,498$622.1K$1.87M1.64%+$1.24M
Dyne Therapeutics, Inc.(DYN)073,150+73,150$0$1.72M1.51%+$1.72M
Savara Inc.(SVRA)200,000508,338+308,338$848.0K$1.56M1.37%+$712.6K
Tango Therapeutics, Inc.(TNGX)599,048474,955-124,093$4.61M$1.47M1.29%-$3.15M
Kura Oncology, Inc.(KURA)0157,959+157,959$0$1.38M1.21%+$1.38M
Incyte Corporation(INCY)018,009+18,009$0$1.24M1.09%+$1.24M
BeOne Medicines AGADR(ONC)06,365+6,365$0$1.18M1.03%+$1.18M
Verastem, Inc.(VSTM)0209,889+209,889$0$1.09M0.95%+$1.09M
89bio Inc595,203132,982-462,221$4.40M$1.04M0.91%-$3.36M
Zenas BioPharma, Inc.(ZBIO)111,605111,6050$1.89M$914.0K0.80%-$974.3K
Capricor Therapeutics, Inc.(CAPR)337,34755,229-282,118$5.13M$762.2K0.67%-$4.37M
Kyverna Therapeutics, Inc.(KYTX)0182,177+182,177$0$681.3K0.60%+$681.3K
Rezolute, Inc.(RZLT)0123,184+123,184$0$603.6K0.53%+$603.6K
Century Therapeutics, Inc.(IPSC)0462,963+462,963$0$467.6K0.41%+$467.6K
Zura Bio LimitedCL A(ZURA)156,626186,943+30,317$635.9K$467.4K0.41%-$168.5K
EyePoint, Inc.(EYPT)049,375+49,375$0$367.8K0.32%+$367.8K
Axsome Therapeutics, Inc.(AXSM)04,268+4,268$0$361.1K0.32%+$361.1K
Madrigal Pharmaceuticals, Inc.(MDGL)01,129+1,129$0$348.4K0.31%+$348.4K
Lexeo Therapeutics, Inc.(LXEO)052,616+52,616$0$346.2K0.30%+$346.2K
Climb Bio, Inc.(CLYM)33,82498,160+64,336$172.2K$176.7K0.16%+$4.5K
Lakeshore Biopharma Co Ltd030,792+30,792$0$106.2K0.09%+$106.2K
Allogene Therapeutics Inc478,1150-478,115$1.34M$0—-$1.34M
Biomea Fusion, Inc.(BMEA)83,5540-83,554$843.9K$0—-$843.9K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)25,4010-25,401$524.0K$0—-$524.0K
Cullinan Therapeutics, Inc.(CGEM)20,8400-20,840$348.9K$0—-$348.9K
Immunovant, Inc.(IMVT)12,4470-12,447$354.9K$0—-$354.9K
Lakeshore Biopharma Co Ltd307,9200-307,920$212.2K$0—-$212.2K
Nkarta, Inc.(NKTX)740,2940-740,294$3.35M$0—-$3.35M
Spyre Therapeutics, Inc.(SYRE)37,2870-37,287$1.10M$0—-$1.10M
Tourmaline Bio Inc29,1040-29,104$748.3K$0—-$748.3K
Page 1 of 1
SUPERSTRING CAPITAL MANAGEMENT LP — 13F Holdings — Q4 2024 | TickerTrail